Clenbuterol vs Liothyronine (T3)

Well Studied vs FDA Approved
monitor Researched · 90% Synergistic for fat loss as T3 increases metabolic rate while clenbuterol stimulates beta-2 adrenergic lipolysis. However, the combination carries significant cardiac risk: both compounds increase heart rate, and T3 upregulates beta-adrenergic receptor density, amplifying clenbuterol's cardiovascular effects. Monitor heart rate and blood pressure closely. Start doses conservatively and do not escalate both simultaneously.

Molecular Data

Clenbuterol Liothyronine (T3)
Weight 277.19 Da 650.97 Da
Half-life ~36 hours ~1 day
Type Sympathomimetic amine (C12H18Cl2N2O) Thyroid hormone (C15H12I3NO4)

Key Benefits

Clenbuterol
01 Increased basal metabolic rate and thermogenesis for accelerated fat loss
02 Preferential mobilization of stored body fat through enhanced lipolysis
03 Anti-catabolic effects that help preserve lean muscle mass during caloric restriction
04 Bronchodilation and improved respiratory capacity during intense exercise
05 Appetite suppression in many users, supporting adherence to caloric deficit
06 Oral administration with no injections required
Liothyronine (T3)
01 Direct and rapid increase in basal metabolic rate
02 Enhanced fat oxidation and lipolysis
03 Improved energy levels and reduction of hypothyroid fatigue
04 Faster-acting than T4 with effects noticeable within hours to days
05 Useful when peripheral T4-to-T3 conversion is impaired (illness, caloric deficit, stress)
06 Supports body temperature regulation and thermogenesis
07 Can improve cognitive clarity and reduce brain fog associated with low thyroid function

Side Effects

Clenbuterol
Tremors and shaking (especially hands) - most pronounced in the first 3-5 days
Tachycardia (elevated heart rate, typically 10-20 bpm above baseline)
Insomnia and sleep disturbance, particularly with afternoon or evening dosing
Muscle cramps (calves, forearms, back) due to taurine depletion
Increased sweating and elevated body temperature
Headaches, particularly during dose ramp-up
Nervousness, anxiety, and restlessness
Increased blood pressure
Liothyronine (T3)
Tachycardia and palpitations (increased heart rate, especially at higher doses)
Anxiety, nervousness, and irritability
Insomnia and disrupted sleep architecture
Increased sweating and heat intolerance
Tremor (fine hand tremor, similar to hyperthyroid presentation)
Increased appetite despite accelerated metabolism
Loose stools or increased bowel frequency
Contraindications
Pre-existing cardiovascular disease, cardiomyopathy, or arrhythmia
Uncontrolled hypertension
Hyperthyroidism or thyrotoxicosis
Hypokalemia or electrolyte imbalances
Known hypersensitivity to clenbuterol or sympathomimetic amines
Concurrent use of other stimulants (ephedrine, amphetamines) or MAO inhibitors
Pregnancy or breastfeeding
Untreated adrenal insufficiency (must correct cortisol deficiency before starting T3)
Acute myocardial infarction or unstable angina
Thyrotoxicosis or untreated hyperthyroidism
Known hypersensitivity to liothyronine or any tablet excipients
Uncorrected adrenal cortical insufficiency (risk of adrenal crisis)

Research Evidence

Clenbuterol Liothyronine (T3)
Status Well Studied FDA Approved
References 5 studies 5 studies
Latest 2021 September 2023
FDA Approved No Yes

This comparison is for educational and research purposes only. Consult a healthcare professional before use.